STAAR SURGICAL CO filed this 4 on 03/16/2026

STAAR SURGICAL CO (Form: 4, Received: 03/16/2026 17:00:58)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Foust Warren	2. Issuer Name and Ticker or Trading Symbol STAAR SURGICAL CO [ STAA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Interim Co-CEO and Pres. & COO
(Last) (First) (Middle) 25510 COMMERCENTRE DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 3/12/2026
(Street) LAKE FOREST, CA 92630	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person
(City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	3/12/2026		M		8,175 ⁽¹⁾	A	$0	34,263	D
Common Stock	3/14/2026		M		19,550 ⁽³⁾	A	$0	53,813	D
Common Stock	3/14/2026		M		9,775 ⁽⁴⁾	A	$0	63,588 ⁽⁵⁾	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0 ⁽⁶⁾	3/12/2026		M			8,175	⁽¹⁾	⁽¹⁾	Common Stock	8,175	$0	8,175	D
Restricted Stock Units	$0 ⁽⁶⁾	3/13/2026		A		45,117		⁽²⁾	⁽²⁾	Common Stock	45,117	$0	45,117	D
Restricted Stock Units	$0 ⁽⁶⁾	3/14/2026		M			19,550	⁽³⁾	⁽³⁾	Common Stock	19,550	$0	39,101	D
Restricted Stock Units	$0 ⁽⁶⁾	3/14/2026		M			9,775	⁽⁴⁾	⁽⁴⁾	Common Stock	9,775	$0	19,551	D

Explanation of Responses:
(1)	Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and will vest as to 1/3 (8,175 shares) on March 12, 2027.
(2)	Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (15,039 shares) on March 13, 2027, 1/3 (15,039 shares) on March 13, 2028, and 1/3 (15,039 shares) on March 13, 2029.
(3)	Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (19,550 shares) on March 14, 2026, and will vest as to 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028.
(4)	Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (9,775 shares) on March 14, 2026, and will vest as to 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028.
(5)	Includes previously granted RSUs, which are subject to future vesting.
(6)	Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Foust Warren 25510 COMMERCENTRE DRIVE LAKE FOREST, CA 92630			Interim Co-CEO and Pres. & COO

Signatures
/s/ Warren Foust		3/16/2026
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.